Galderma’s Phase III OLYMPIA 1 Data Published in JAMA Dermatology Demonstrate That Nemolizumab Improves Core Signs and Symptoms of Prurigo Nodularis
BWI
10 min read
30

Galderma’s Phase III OLYMPIA 1 Data Published in JAMA Dermatology Demonstrate That Nemolizumab Improves Core Signs and Symptoms of Prurigo Nodularis

November 29, 2024
0

Reading Time: 7 minutes Zug, Switzerland:   Full results from the phase III OLYMPIA 1 trial evaluating the efficacy and safety of nemolizumab in adults with moderate-to-severe prurigo nodularis have been published in JAMA Dermatology, showing the trial met all primary and key secondary endpoints1

Continue Reading
CSP
41 min read
10

Notice to attend the extraordinary general meeting in OssDsign AB

November 29, 2024
0

Reading Time: 29 minutes The shareholders in OssDsign AB, reg. no. 556841-7546, are hereby given notice to attend the extraordinary general meeting at 10:00 am on Wednesday 18 December 2024 at Setterwalls Advokatbyrå’s offices at address Sturegatan 10 in Stockholm. Registration for the meeting commences 30

Continue Reading
CSP
1 min read
7

#24-409 Listing of Derivatives at NGM

November 29, 2024
0

Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market

Continue Reading
CSP
2 min read
11

Europi Property Group AB (publ) successfully issues senior unsecured green bonds

November 29, 2024
0

Reading Time: 2 minutes NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OR TO ANY PERSON LOCATED OR RESIDENT IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES TO DISTRIBUTE THIS ANNOUNCEMENT.

Continue Reading
CSP
3 min read
8

STENOCARE Celebrates Denmark’s Permanent Legalisation of Medical Cannabis

November 29, 2024
0

Reading Time: 2 minutes STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER:  STENO Today, the Danish parliament formally agreed on permanent legalisation of medical cannabis. This is fantastic news for both Danish patients and Stenocare, as it ensures continued access to and the sale of medical cannabis

Continue Reading
CSP
18 min read
10

SyntheticMR resolves on a rights issue of approximately SEK 65 million

November 28, 2024
0

Reading Time: 12 minutes THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OF AMERICA, OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR

Continue Reading
CSP
15 min read
7

NOTICE OF EXTRAORDINARY GENERAL MEETING IN PEPTONIC MEDICAL AB

November 28, 2024
0

Reading Time: 11 minutes N.B. This English text is an unofficial translation of the Swedish original of the notice to attend the extraordinary general meeting in PEPTONIC medical AB, and in case of any discrepancies between the Swedish and the English translation, the Swedish text shall

Continue Reading
CSP
2 min read
10

Electrolux Professional Group among the world’s 500 best companies in Sustainable Growth

November 28, 2024
0

Reading Time: 2 minutes Electrolux Professional Group is among the 500 companies ranked in the World’s Best Companies – Sustainable Growth 2025 benchmark list by TIME and Statista, identifying companies around the world demonstrating both outstanding financial and environmental performance. To understand which companies are

Continue Reading
CSP
1 min read
9

Gentoo Media – Mandatory notification of trade

November 28, 2024
0

Reading Time: < 1 minute MJ Foundation Fundacja Rodzinna, a company related to Mateusz Juroszek, Board Member and primary insider of Gentoo Media Inc. (Gentoo) has today acquired 7,811 shares in Gentoo at a price of SEK 24.30 per share. After this transaction, close associates

Continue Reading
CSP
12 min read
12

Irisity AB (publ) announces outcome in the rights issue

November 28, 2024
0

Reading Time: 8 minutes NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, THE UNITED STATES OR IN ANY OTHER JURISDICTION WHERE SUCH RELEASE, DISTRIBUTION,

Continue Reading